| Creasensor: SIMPLE technology for creatinine detection in plasma F Dal Dosso, D Decrop, E Pérez-Ruiz, D Daems, H Agten, O Al-Ghezi, ... Analytica chimica acta 1000, 191-198, 2018 | 41 | 2018 |
| Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer R Saesen, M Van Hemelrijck, J Bogaerts, CM Booth, JJ Cornelissen, ... European Journal of Cancer 186, 52-61, 2023 | 35 | 2023 |
| Views of European drug development stakeholders on treatment optimization and its potential for use in decision-making R Saesen, S Lejeune, G Quaglio, D Lacombe, I Huys Frontiers in Pharmacology 11, 43, 2020 | 21 | 2020 |
| Design, organisation and impact of treatment optimisation studies in breast, lung and colorectal cancer: The experience of the European Organisation for Research and Treatment … R Saesen, D Lacombe, I Huys European Journal of Cancer 151, 221-232, 2021 | 12 | 2021 |
| Real-world data in oncology: a questionnaire-based analysis of the academic research landscape examining the policies and experiences of the cancer cooperative groups R Saesen, D Lacombe, I Huys ESMO open 8 (2), 100878, 2023 | 11 | 2023 |
| Establishing treatment optimisation as part of personalised medicine development D Lacombe, G Quaglio, S Lejeune, R Saesen, P Rübig European Journal of Cancer 113, 96-97, 2019 | 10 | 2019 |
| How to balance valuable innovation with affordable access to medicines in Belgium? S Simoens, K Abdallah, L Barbier, TB Lacosta, A Blonda, E Car, ... Frontiers in Pharmacology 13, 960701, 2022 | 9 | 2022 |
| Past, current, and future cancer clinical research collaborations: the case of the European Organisation for Research and Treatment of Cancer S Broes, R Saesen, D Lacombe, I Huys Clinical and Translational Science 14 (1), 47-53, 2021 | 8 | 2021 |
| How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and … R Saesen, G Kantidakis, A Marinus, D Lacombe, I Huys Frontiers in Pharmacology 13, 969778, 2022 | 7 | 2022 |
| Advancing academia-driven treatment optimisation in oncology: Launch of the EMA Cancer Medicines Forum R Saesen, C Espinasse, F Pignatti, D Lacombe European Journal of Cancer 168, 77-79, 2022 | 4 | 2022 |
| Characteristics of early phase clinical trials for rare cancers: insights from interviews with stakeholders M Dooms, R Saesen, I Steemans, J Lansens, I Huys Frontiers in Pharmacology 13, 775217, 2022 | 3 | 2022 |
| Patients’ knowledge, preferences, and perspectives about data protection and data control: an exploratory survey T Lalova-Spinks, R Saesen, M Silva, J Geissler, I Shakhnenko, ... Frontiers in Pharmacology 14, 1280173, 2024 | 2 | 2024 |
| Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments R Saesen, K Depreytere, K Krupianskaya, J Langeweg, J Verheecke, ... BMC Medical Research Methodology 23 (1), 148, 2023 | 2 | 2023 |
| Involvement of the European Medicines Agency in multi-stakeholder regulatory science research projects: experiences of staff members and project coordinators R Saesen, M Machado, B Crifo, L Liu, C de Vries, R Herold, ... Frontiers in Medicine 10, 1181702, 2023 | 2 | 2023 |
| COVID-19 clinical trials: see it big and keep it simple R Saesen, I Huys BMJ Evidence-Based Medicine 26 (4), 147-148, 2021 | 2 | 2021 |
| Accelerating regulatory approval of anticancer therapies: Benefits, drawbacks and recommendations for a more sustainable approach. R Saesen, D Lacombe, I Huys Journal of Cancer Policy 29, 100296-100296, 2021 | 1 | 2021 |
| HIV-positive men as a key population for fighting HIVDR in Africa J Herrmann, J Lushaba, L Michielsen, N Quirós, R Saesen, C Louw, ... Transdisciplinary Insights 2 (1), 78-91, 2018 | 1 | 2018 |
| PCR19 The EU Patient Community's Perspectives on Data Protection and Data Control T Lalova-Spinks, R Saesen, M Silva, J Geissler, I Shakhnenko, ... Value in Health 26 (12), S452, 2023 | | 2023 |
| Balancing Innovation With Optimization in Oncology: Avenues for Bridging the Cancer Clinical Research Gap R Saesen, I Huys, D Lacombe | | 2023 |
| An Official Journal of the European Society for Medical Oncology T El-Galaly, JN Kather, M Koopman, I Vaz-Luis, A Vogel, M Vakalopoulou, ... | | 2023 |
